IOVA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $503,000.00

Iovance Biotherapeutics Insider Trading History Chart

Iovance Biotherapeutics Share Price & Price History

^$3.27

▲ +0.42 (14.74%)

As of 04/9/2025 05:00 PM ET

Days: 30 | 90 | 365

Iovance Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Ryan D. Maynard	Director	Sell	50,000	$10.06	$503,000.00	7,500
2/20/2024	Merrill A Mcpeak	Director	Buy	250,000	$9.15	$2,287,500.00	320,150
9/18/2023	Merrill A Mcpeak	Director	Buy	10,000	$5.56	$55,600.00	248,633
9/15/2023	Wayne P. Rothbaum	Director	Buy	5,000,000	$5.30	$26,500,000.00	23,067,333
12/21/2022	Merrill A Mcpeak	Director	Buy	10,000	$6.15	$61,500.00	70,150
12/2/2022	Wayne P. Rothbaum	Director	Buy	10,000,000	$6.50	$65,000,000.00	18,067,333
11/28/2022	Frederick G. Vogt	CEO	Buy	1,000	$5.98	$5,980.00	2,000
11/28/2022	Merrill A Mcpeak	Director	Buy	10,000	$6.18	$61,800.00	228,633
11/23/2022	Iain D. Dukes	Director	Buy	10,000	$6.10	$61,000.00	22,000
6/1/2022	Frederick G. Vogt	CEO	Buy	1,000	$6.44	$6,440.00	1,000
5/31/2022	Merrill A Mcpeak	Director	Buy	10,000	$6.84	$68,400.00	20,150

SEC Filings (Institutional Ownership Changes) for Iovance Biotherapeutics (NASDAQ:IOVA)

77.03% of Iovance Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Iovance Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	117,426	$0.87M	0.0%	-9.3%	0.036%
3/18/2025	California State Teachers Retirement System	203,241	$1.50M	0.0%	+7.3%	0.062%
3/17/2025	Wealth Enhancement Advisory Services LLC	18,738	$0.14M	0.0%	-23.2%	0.006%
3/6/2025	Arcadia Wealth Management Inc.	15,750	$0.12M	0.1%	N/A	0.005%
2/25/2025	B. Riley Wealth Advisors Inc.	19,442	$0.14M	0.0%	+39.4%	0.006%
2/19/2025	GF Fund Management CO. LTD.	6,400	$47K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	453,138	$3.35M	0.7%	N/A	0.149%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,907,727	$14.12M	0.0%	-2.0%	0.626%
2/17/2025	Soleus Capital Management L.P.	6,560,000	$48.54M	3.1%	-23.1%	2.152%
2/17/2025	Stempoint Capital LP	949,401	$7.03M	1.7%	N/A	0.312%
2/17/2025	Shay Capital LLC	25,400	$0.19M	0.0%	N/A	0.008%
2/17/2025	Sherbrooke Park Advisers LLC	19,090	$0.14M	0.0%	N/A	0.006%
2/17/2025	Rafferty Asset Management LLC	554,141	$4.10M	0.0%	-15.1%	0.182%
2/17/2025	Raiffeisen Bank International AG	102,000	$0.73M	0.0%	N/A	0.033%
2/17/2025	ProShare Advisors LLC	91,775	$0.68M	0.0%	+39.5%	0.030%
2/17/2025	MPM Bioimpact LLC	2,673,905	$19.79M	2.8%	+11.1%	0.877%
2/17/2025	Man Group plc	2,414,996	$17.87M	0.0%	N/A	0.792%
2/17/2025	Nuveen Asset Management LLC	1,683,208	$12.46M	0.0%	+27.3%	0.552%
2/17/2025	Millennium Management LLC	75,494	$0.56M	0.0%	-50.0%	0.025%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	178,303	$1.31M	0.0%	+8.5%	0.059%
2/17/2025	Ensign Peak Advisors Inc	577,265	$4.27M	0.0%	+673.9%	0.189%
2/17/2025	Fullcircle Wealth LLC	10,000	$74K	0.0%	N/A	0.003%
2/17/2025	D. E. Shaw & Co. Inc.	30,812	$0.23M	0.0%	-54.5%	0.010%
2/17/2025	Deutsche Bank AG	867,576	$6.42M	0.0%	+14.8%	0.285%
2/17/2025	Cresset Asset Management LLC	78,302	$0.58M	0.0%	-3.1%	0.026%
2/17/2025	Cetera Investment Advisers	25,794	$0.19M	0.0%	-9.8%	0.008%
2/17/2025	Brevan Howard Capital Management LP	11,962	$89K	0.0%	-64.9%	0.004%
2/17/2025	Captrust Financial Advisors	28,738	$0.21M	0.0%	-42.1%	0.009%
2/17/2025	Baird Financial Group Inc.	195,845	$1.45M	0.0%	+1.0%	0.064%
2/17/2025	Bank of America Corp DE	741,418	$5.49M	0.0%	-69.7%	0.243%
2/17/2025	BNP Paribas Financial Markets	53,281	$0.39M	0.0%	-53.1%	0.017%
2/17/2025	Ameriprise Financial Inc.	62,548	$0.46M	0.0%	-88.8%	0.021%
2/17/2025	Algert Global LLC	56,400	$0.42M	0.0%	+4.3%	0.019%
2/17/2025	Apis Capital Advisors LLC	1,363,000	$10.09M	6.7%	+101.9%	0.447%
2/17/2025	683 Capital Management LLC	1,416,014	$10.48M	0.7%	+1.1%	0.465%
2/14/2025	Boxer Capital Management LLC	750,000	$5.55M	0.5%	N/A	0.246%
2/14/2025	One68 Global Capital LLC	10,000	$74K	0.0%	N/A	0.003%
2/14/2025	Schonfeld Strategic Advisors LLC	64,850	$0.48M	0.0%	-83.6%	0.021%
2/14/2025	Northern Trust Corp	2,414,807	$17.87M	0.0%	+7.4%	0.792%
2/14/2025	The Manufacturers Life Insurance Company	279,627	$2.07M	0.0%	-10.3%	0.092%
2/14/2025	Quarry LP	10,000	$74K	0.0%	N/A	0.003%
2/14/2025	Virtus ETF Advisers LLC	43,927	$0.33M	0.1%	+12.4%	0.014%
2/14/2025	Nebula Research & Development LLC	71,964	$0.53M	0.1%	-19.9%	0.024%
2/14/2025	Voya Investment Management LLC	169,737	$1.26M	0.0%	-1.9%	0.056%
2/14/2025	Hood River Capital Management LLC	8,991,573	$66.54M	1.0%	+10.4%	2.950%
2/14/2025	T. Rowe Price Investment Management Inc.	5,834,456	$43.18M	0.0%	-0.5%	1.914%
2/14/2025	Long Focus Capital Management LLC	5,132,000	$37.98M	1.2%	+13.2%	1.684%
2/14/2025	Price T Rowe Associates Inc. MD	2,628,101	$19.45M	0.0%	-15.3%	0.862%
2/14/2025	Dark Forest Capital Management LP	16,902	$0.13M	0.0%	-31.7%	0.006%
2/14/2025	Hsbc Holdings PLC	31,945	$0.23M	0.0%	+78.5%	0.010%
2/14/2025	Avoro Capital Advisors LLC	3,500,000	$25.90M	0.4%	-17.5%	1.148%
2/14/2025	B Group Inc.	992,000	$7.34M	4.5%	N/A	0.325%
2/14/2025	Stifel Financial Corp	209,999	$1.55M	0.0%	-5.9%	0.069%
2/14/2025	Tower Research Capital LLC TRC	44,390	$0.33M	0.0%	+91.1%	0.015%
2/14/2025	MetLife Investment Management LLC	165,842	$1.23M	0.0%	+13.3%	0.054%
2/14/2025	Dimensional Fund Advisors LP	2,430,221	$17.98M	0.0%	+17.4%	0.797%
2/14/2025	First Trust Advisors LP	324,246	$2.40M	0.0%	N/A	0.106%
2/13/2025	CANADA LIFE ASSURANCE Co	57,265	$0.42M	0.0%	-5.7%	0.019%
2/13/2025	Marshall Wace LLP	1,130,455	$8.37M	0.0%	N/A	0.371%
2/13/2025	NFJ Investment Group LLC	187,342	$1.39M	0.0%	-1.2%	0.061%
2/13/2025	Integrity Wealth Advisors Inc.	10,395	$77K	0.1%	N/A	0.003%
2/13/2025	Jump Financial LLC	10,619	$79K	0.0%	N/A	0.003%
2/13/2025	Guggenheim Capital LLC	98,940	$0.73M	0.0%	-9.9%	0.032%
2/13/2025	Mariner LLC	16,033	$0.12M	0.0%	-13.4%	0.005%
2/13/2025	Barclays PLC	617,803	$4.57M	0.0%	+2.2%	0.203%
2/13/2025	Summit Investment Advisors Inc.	28,729	$0.21M	0.2%	+15.8%	0.009%
2/13/2025	Rockefeller Capital Management L.P.	46,417	$0.34M	0.0%	+7.6%	0.015%
2/13/2025	Capital Fund Management S.A.	190,183	$1.41M	0.0%	-56.8%	0.062%
2/13/2025	Legal & General Group Plc	232,654	$1.72M	0.0%	-4.5%	0.076%
2/13/2025	Invesco Ltd.	221,928	$1.64M	0.0%	+2.3%	0.073%
2/13/2025	Dynamic Technology Lab Private Ltd	17,945	$0.13M	0.0%	N/A	0.006%
2/13/2025	Rhenman & Partners Asset Management AB	1,235,448	$9.14M	0.9%	+17.4%	0.405%
2/13/2025	Wells Fargo & Company MN	580,245	$4.29M	0.0%	+0.8%	0.190%
2/13/2025	Orion Investment Co	1,060,755	$7.85M	3.1%	+17.0%	0.348%
2/12/2025	Landscape Capital Management L.L.C.	106,884	$0.79M	0.1%	+63.1%	0.035%
2/12/2025	Arete Wealth Advisors LLC	25,750	$0.19M	0.0%	-25.6%	0.008%
2/12/2025	Cinctive Capital Management LP	329,204	$2.44M	0.1%	N/A	0.108%
2/12/2025	Headlands Technologies LLC	25,725	$0.19M	0.0%	N/A	0.008%
2/12/2025	Geode Capital Management LLC	5,871,420	$43.46M	0.0%	+3.9%	1.926%
2/12/2025	Alliancebernstein L.P.	765,399	$5.66M	0.0%	+21.3%	0.251%
2/12/2025	Pier 88 Investment Partners LLC	54,630	$0.40M	0.1%	+23.7%	0.018%
2/12/2025	Wellington Management Group LLP	117,426	$0.87M	0.0%	-9.3%	0.039%
2/12/2025	DnB Asset Management AS	40,778	$0.30M	0.0%	+27.7%	0.013%
2/12/2025	Pictet Asset Management Holding SA	831,059	$6.15M	0.0%	-7.9%	0.273%
2/12/2025	Norges Bank	416,237	$3.08M	0.0%	N/A	0.137%
2/12/2025	JPMorgan Chase & Co.	1,306,826	$9.67M	0.0%	-29.1%	0.429%
2/12/2025	Artisan Partners Limited Partnership	4,542,168	$33.61M	0.1%	-5.4%	1.490%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	29,684	$0.23M	0.0%	+16.4%	0.010%
2/11/2025	Prudential Financial Inc.	31,700	$0.24M	0.0%	+83.8%	0.010%
2/11/2025	Vanguard Group Inc.	27,534,340	$203.75M	0.0%	+0.8%	9.034%
2/11/2025	LPL Financial LLC	250,707	$1.86M	0.0%	+2.6%	0.082%
2/11/2025	KLP Kapitalforvaltning AS	40,700	$0.30M	0.0%	N/A	0.013%
2/11/2025	Sei Investments Co.	478,481	$3.54M	0.0%	+1.9%	0.157%
2/11/2025	American Century Companies Inc.	126,654	$0.94M	0.0%	-36.3%	0.042%
2/11/2025	Virtu Financial LLC	63,276	$0.47M	0.0%	N/A	0.021%
2/11/2025	Sciencast Management LP	13,569	$100K	0.0%	N/A	0.004%
2/11/2025	Magnetar Financial LLC	14,623	$0.11M	0.0%	N/A	0.005%
2/11/2025	Teacher Retirement System of Texas	63,025	$0.47M	0.0%	+28.3%	0.021%
2/11/2025	Kazazian Asset Management LLC	11,400	$84K	0.1%	N/A	0.004%
2/11/2025	Xponance Inc.	19,607	$0.15M	0.0%	+18.5%	0.006%

Data available starting January 2016

See Full Table

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

Today's Range

Now: $3.27

$2.74

$3.37

50 Day Range

MA: $4.42

$2.85

$6.21

52 Week Range

Now: $3.27

$2.70

$14.23

Volume

17,764,918 shs

Average Volume

7,339,531 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Iovance Biotherapeutics?: Iovance Biotherapeutics' top insider shareholders include:
Wayne P Rothbaum (Director)
Merrill A Mcpeak (Director)
Ryan D Maynard (Director)
Learn More about top insider investors at Iovance Biotherapeutics.